158 related articles for article (PubMed ID: 33219317)
1. UFBP1, a key component in ufmylation, enhances drug sensitivity by promoting proteasomal degradation of oxidative stress-response transcription factor Nrf2.
Hu Z; Wang X; Li D; Cao L; Cui H; Xu G
Oncogene; 2021 Jan; 40(3):647-662. PubMed ID: 33219317
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and Biochemical Analyses Reveal a Novel Mechanism for Promoting Protein Ubiquitination and Degradation by UFBP1, a Key Component of Ufmylation.
Zhu Y; Lei Q; Li D; Zhang Y; Jiang X; Hu Z; Xu G
J Proteome Res; 2018 Apr; 17(4):1509-1520. PubMed ID: 29533670
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
4. UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development.
Cai Y; Pi W; Sivaprakasam S; Zhu X; Zhang M; Chen J; Makala L; Lu C; Wu J; Teng Y; Pace B; Tuan D; Singh N; Li H
PLoS Genet; 2015 Nov; 11(11):e1005643. PubMed ID: 26544067
[TBL] [Abstract][Full Text] [Related]
5. Ufmylation of UFBP1 Is Dispensable for Endoplasmic Reticulum Stress Response, Embryonic Development, and Cardiac and Intestinal Homeostasis.
Tandra V; Anderson T; Ayala JD; Weintraub NL; Singh N; Li H; Li J
Cells; 2023 Jul; 12(15):. PubMed ID: 37566002
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis.
Lemaire K; Moura RF; Granvik M; Igoillo-Esteve M; Hohmeier HE; Hendrickx N; Newgard CB; Waelkens E; Cnop M; Schuit F
PLoS One; 2011 Apr; 6(4):e18517. PubMed ID: 21494687
[TBL] [Abstract][Full Text] [Related]
7. NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in
Gambardella V; Gimeno-Valiente F; Tarazona N; Martinez-Ciarpaglini C; Roda D; Fleitas T; Tolosa P; Cejalvo JM; Huerta M; Roselló S; Castillo J; Cervantes A
Clin Cancer Res; 2019 Mar; 25(5):1639-1649. PubMed ID: 30504425
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract][Full Text] [Related]
9. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.
Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J
Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731
[TBL] [Abstract][Full Text] [Related]
10. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
11. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
[TBL] [Abstract][Full Text] [Related]
12. Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses.
Biswas C; Shah N; Muthu M; La P; Fernando AP; Sengupta S; Yang G; Dennery PA
J Biol Chem; 2014 Sep; 289(39):26882-26894. PubMed ID: 25107906
[TBL] [Abstract][Full Text] [Related]
13. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
Ciamporcero E; Daga M; Pizzimenti S; Roetto A; Dianzani C; Compagnone A; Palmieri A; Ullio C; Cangemi L; Pili R; Barrera G
Free Radic Biol Med; 2018 Feb; 115():447-457. PubMed ID: 29248722
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.
Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK
Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032
[TBL] [Abstract][Full Text] [Related]
16. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
17. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
18. Mazes of Nrf2 Regulation.
Zenkov NK; Kozhin PM; Chechushkov AV; Martinovich GG; Kandalintseva NV; Menshchikova EB
Biochemistry (Mosc); 2017 May; 82(5):556-564. PubMed ID: 28601065
[TBL] [Abstract][Full Text] [Related]
19. Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR.
Zhu H; Bhatt B; Sivaprakasam S; Cai Y; Liu S; Kodeboyina SK; Patel N; Savage NM; Sharma A; Kaufman RJ; Li H; Singh N
Nat Commun; 2019 Mar; 10(1):1084. PubMed ID: 30842412
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection.
Sebens S; Bauer I; Geismann C; Grage-Griebenow E; Ehlers S; Kruse ML; Arlt A; Schäfer H
J Biol Chem; 2011 Nov; 286(47):40911-21. PubMed ID: 21990354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
